Revisiting B-cell targeted therapies in rheumatoid arthritis: from paradoxical biology to deep immune reset - Top-Institutions - MDSpire

Revisiting B-cell targeted therapies in rheumatoid arthritis: from paradoxical biology to deep immune reset

  • By

  • Min Huang

  • Fangbing Dong

  • Qiaomei Liu

  • Shaofang Lin

  • May 4, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Rheumatology

  • #2

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Rheumatology

Original Source(s)

Revisiting B-cell targeted therapies in rheumatoid arthritis: from paradoxical biology to deep immune reset

  • by Min Huang, Fangbing Dong, Qiaomei Liu, Shaofang Lin

  • May 4, 2026

Related Content

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma

Reduced-intensity versus intensive induction in high-risk acute promyelocytic leukemia: a systematic review and meta-analysis

Case Report: Unexpected LAMS obstruction following successful EUS-BD in a patient with pancreatic carcinoma